Magnesium deficiency increases risk of CRP elevation

June 14, 2005 Printer Friendly
In this issue

Life Extension Update Exclusive:

Magnesium deficiency increases risk of CRP elevation



Featured Products:


Magnesium capsules

CRP blood test

Life Extension

It’s not too late! Register onsite at the National Conference on Prostate Cancer 2005

Life Extension Update Exclusive

Magnesium deficiency increases risk of CRP elevation

A study published in the June 2005 issue of the Journal of the American College of Nutrition ( found that the majority of a sampling of Americans did not consume adequate magnesium, and that deficient dietary levels of the mineral are correlated with an elevation of C-reactive protein (CRP), a marker of inflammation and cardiovascular disease risk.

Researchers from the Medical University of South Carolina in Charleston analyzed 5,021 participants in the National Health and Nutrition examination Survey 1999-2000 (NHANES 99-00), which was conducted by the National Center for Health Statistics to collect information concerning the health and diet of American men and women. Dietary information was obtained through subject interviews and CRP levels were measured as a part of NHANES 99-00 physical and laboratory examination.

The average daily intake of magnesium among the subjects included in the current study was 328 milligrams. Sixty-eight percent consumed less than the recommended daily allowance (RDA) of the mineral (410 milligrams for men and 360 milligrams for women aged 14 to 18, 400 milligrams for men and 310 milligrams for women aged 19-30, and 420 milligrams for men and 320 milligrams for women aged 31 and older). When the 3,799 participants who were not taking magnesium-containing supplements were analyzed, 78.5 percent were found to have an intake that was less than the RDA.

C-reactive protein levels were elevated (greater than or equal to 3.0 milligrams per liter) in 35.5 percent of the participants. Those who consumed less than the RDA of magnesium were 1.48 to 1.75 times more likely to have an elevated CRP level than those who consumed the RDA or greater. Participants who did not use magnesium-containing supplements experienced a greater risk of having elevated CRP when magnesium levels were deficient than that experienced by the entire study population. Increased body mass index and deficient magnesium more than doubled the risk of having elevated CRP in men and women over the age of 40 compared to those whose magnesium intake was at least the recommended daily allowance.

The authors note that magnesium intake even slightly below the RDA elevated CRP. They speculate that increased oxidative stress or endothelial dysfunction could be the mechanism by which inadequate magnesium increases the risk of having elevated CRP. “Correction of low magnesium intake (below the RDA) through more emphasis on the AHA dietary guidelines and/or through magnesium supplementation may provide an important means to reduce CRP levels and perhaps cardiovascular risk,” they write.


Inflammation (Chronic)

The New England Journal of Medicine published several studies in the year 2000 showing that the blood indicators of inflammation are strong predictive factors for determining who will suffer a heart attack (Lindahl et al. 2000; Packard et al. 2000; Rader 2000). The January 2001 issue of Life Extension Magazine described these studies and explained how individuals could protect themselves against these inflammatory markers (such as C-reactive protein, homocysteine, and fibrinogen).

A growing consensus among scientists is that common disorders such as atherosclerosis, colon cancer, and Alzheimer's disease are all caused in part by a chronic inflammatory syndrome.

The Life Extension Foundation long ago advised members to have an annual C-reactive protein blood test to detect systemic inflammation that could increase the risk of heart attack, stroke, cancer and a host of age-related diseases. In fact, on January 28, 2003 , the American Heart Association and Centers for Disease Control & Prevention (CDC) jointly endorsed the C-reactive protein test to screen for coronary-artery inflammation to identify those at risk for heart attack.

Those who are in relative good health, but have elevated C-reactive protein, can try to lower it using a variety of diet modifications, supplements and/or drugs. Supplements such as vitamin E, borage oil, fish oil, DHEA, vitamin K and nettle leaf extract can lower C-reactive protein. Diets low in arachidonic acid, omega-6 fatty acids, saturated fats, high-glycemic food and overcooked food can suppress inflammatory factors in the body.

Featured Products

Magnesium capsules

Many Americans do not obtain adequate amounts of magnesium in their diets.   Magnesium is so inexpensive that everyone should consider supplementing at least 500 mg of magnesium daily. This product provides one of the highest concentrations of elemental magnesium per capsule available on the market.

C-reactive protein blood test

This test is used to assess risk of cardiovascular and peripheral vascular disease.

It’s not too late!

Register onsite at the National Conference on Prostate Cancer 2005 held at the Omni Shoreham Hotel, Washington, DC, June 16-19, 2005.

Who Should Attend?

  • Prostate Cancer patients and survivors 
  • Spouses, partners and family members (especially sons) 
  • Medical professionals who desire to learn more about prostate cancer

Questions? Comments? Send them to or call 1-800-678-8989.

For longer life,

Dayna Dye
Editor, Life Extension Update
1100 West Commercial Boulevard
Fort Lauderdale FL 33309
954 766 8433 extension 7716

Sign up for Life Extension Update

Help spread the good news about living longer and healthier. Forward this email to a friend!

View previous issues of Life Extension Update in the Newsletter Archive.